Phio Pharmaceuticals Corp (PHIO) Stock Price, Quote & News

Company Profile

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RX...

Industry: Biotechnology

Sector: Healthcare

Phone: 610 947 0251

Website: phiopharma.com

Address:

411 Swedeland Road, Suite 23-1080, King of Prussia, United States

PitaPierogi Aug. 4 at 1:45 PM

$PHIO so you're confident we won't have data centers on pluto? $SPCX $TSLA $AMZN

0 · Reply

HaroldH Aug. 4 at 12:09 PM

$PHIO Noise? All I can hear is silence. Except, in the background there is the tic, tic, tic of a clock saying time is money. And, faintly, the nervous rustle of pumpers preparing to abandon ship. I remain bearish.

1 · Reply

MambaMentality7 Jul. 31 at 11:56 AM

$PHIO Don’t listen to the noise. Stay resilient and trust your thesis. Read the tape. The market was at its lowest in over a year and PHIO WENT UP! That means institutional money is not letting it crash, ask yourself why? It’s because the stock has value and good news is coming. It may not be today, or even next week but it’s coming. Ppl will have their opinions and that’s ok, but think like SMART MONEY. They’re just laying the trap to get you out so they can go it alone. When the stock is up $14 then that’s when they need you, so they can offload their high ass shares to you in the excitement. I will be glad to sell you my shares at that price too if you get shook out now:)

0 · Reply

DERDER Jul. 30 at 10:16 PM

$PHIO The new BOD Todd Plott just filed a form 3, and owns 10% of PHIO stock. With his years of experience, resume, knowledge and expertise, that’s really good news…

1 · Reply

WildernessRefuge Jul. 30 at 5:20 PM

$PHIO ALNY, Alnylam Pharmaceutical, PHIO's soon to be little sister, is on sale today.

0 · Reply

HaroldH Jul. 30 at 8:21 AM

$PHIO John Tuld's speech in Margin Call seems relevant for the little $PHIO pumpers. "I'm here to guess what the music might do a week, a month, a year from now. That's it. Nothing more. And standing here tonight, I'm afraid that I don't hear a thing. Just...silence."

1 · Reply

HaroldH Jul. 29 at 1:53 PM

$PHIO No pumpers about today. Was there not much encouraging in Bob's talk yesterday? Are the former pumpers quietly dumping today? Time is money. I remain bearish.

1 · Reply

DosGatos Jul. 28 at 9:34 PM

$PHIO

0 · Reply

masteroffnone Jul. 28 at 7:55 PM

$PHIO any news on today's presentation?

0 · Reply

DERDER Jul. 27 at 6:49 PM

$PHIO

0 · Reply

Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Jul 22, 2026, 7:00 AM EDT - 13 days ago

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Jul 21, 2026, 7:00 AM EDT - 14 days ago

Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors

Jul 15, 2026, 7:00 AM EDT - 20 days ago

Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision

Jun 29, 2026, 12:00 PM EDT - 5 weeks ago

Phio Pharmaceuticals Transcript: Fireside chat

Jun 25, 2026, 3:00 PM EDT - 5 weeks ago

Phio Pharmaceuticals Transcript: Life Sciences Virtual Investor Forum

Jun 24, 2026, 7:00 AM EDT - 5 weeks ago

Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762

May 7, 2026, 4:05 PM EDT - 3 months ago

Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update

May 7, 2026, 7:00 AM EDT - 3 months ago

Phio Pharmaceuticals Quarterly report: Q1 2026

May 7, 2026, 7:00 AM EDT - 3 months ago

Phio Pharmaceuticals Earnings release: Q1 2026

Apr 15, 2026, 12:00 PM EDT - 3 months ago

Phio Pharmaceuticals Transcript: Fireside chat

Apr 14, 2026, 10:30 AM EDT - 4 months ago

Phio Pharmaceuticals Transcript: Second Annual Centri Capital Conference

Apr 13, 2026, 7:00 AM EDT - 4 months ago

Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026

Mar 30, 2026, 7:00 AM EDT - 4 months ago

Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762

Mar 23, 2026, 7:00 AM EDT - 4 months ago

Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement

Mar 16, 2026, 11:30 AM EDT - 5 months ago

Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office

Mar 12, 2026, 11:00 AM EDT - 5 months ago

Phio Pharmaceuticals Transcript: Life Sciences Virtual Investor Forum

Mar 10, 2026, 8:35 AM EDT - 5 months ago

Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT

Mar 10, 2026, 7:00 AM EDT - 5 months ago

Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT

Mar 5, 2026, 4:05 PM EST - 5 months ago

Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update

Mar 5, 2026, 4:00 PM EST - 5 months ago

Phio Pharmaceuticals Annual report: Q4 2025

Mar 5, 2026, 4:00 PM EST - 5 months ago

Phio Pharmaceuticals Earnings release: Q4 2025

Feb 24, 2026, 7:00 AM EST - 5 months ago

Phio Pharmaceuticals Slides: Corporate presentation

Feb 10, 2026, 7:00 AM EST - 6 months ago

Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial

Jan 26, 2026, 8:15 AM EST - 6 months ago

Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

Jan 20, 2026, 9:30 AM EST - 7 months ago

Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial

Jan 15, 2026, 8:45 AM EST - 7 months ago

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026

Dec 23, 2025, 8:45 AM EST - 8 months ago

Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762

Nov 25, 2025, 11:30 AM EST - 9 months ago

Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762

2025-11-20T21:11:11.000Z - 9 months ago

Phio Pharmaceuticals files to sell 11.76M shares of common stock for holders

Nov 20, 2025, 7:00 AM EST - 9 months ago

Phio Pharmaceuticals Registration statement: Registration Filing

Nov 17, 2025, 8:45 AM EST - 9 months ago

Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress

Nov 13, 2025, 4:15 PM EST - 9 months ago

Phio Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 13, 2025, 7:00 AM EST - 9 months ago

Phio Pharmaceuticals Earnings release: Q3 2025

Nov 13, 2025, 7:00 AM EST - 9 months ago

Phio Pharmaceuticals Quarterly report: Q3 2025

Nov 7, 2025, 10:30 AM EST - 9 months ago

Phio Pharmaceuticals to Present Recent Clinical Results from Skin Cancer Trial with siRNA based INTASYL PH-762

Nov 7, 2025, 7:45 AM EST - 9 months ago

Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program

Nov 3, 2025, 1:40 PM EST - 9 months ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $13.4 Million Gross Proceeds

2025-11-03T14:24:44.000Z - 9 months ago

Why Is Phio Pharmaceuticals Stock Up 75% Today?

Nov 3, 2025, 7:45 AM EST - 9 months ago

Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial

Oct 31, 2025, 10:15 AM EDT - 9 months ago

Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director

Sep 18, 2025, 7:45 AM EDT - 11 months ago

Phio Pharmaceuticals to Present at the Life Sciences Future Conference

Sep 3, 2025, 7:45 AM EDT - 11 months ago

Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 28, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Proxy statement: Proxy Filing

Aug 15, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Registration statement: Registration Filing

2025-08-15T10:10:23.000Z - 1 year ago

Phio Pharmaceuticals files to sell 1.93M shares of common stock for holders

Aug 14, 2025, 4:15 PM EDT - 1 year ago

Phio Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Earnings release: Q2 2025

Aug 14, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Quarterly report: Q2 2025

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Proxy statement: Proxy Filing

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Proxy statement: Proxy Filing

Jul 25, 2025, 3:04 PM EDT - 1 year ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

Jul 25, 2025, 12:36 PM EDT - 1 year ago

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort

Jul 25, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance

Jun 25, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort

Jun 24, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

Jun 6, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio

2025-06-05T10:15:09.000Z - 1 year ago

Phio Pharmaceuticals assumed with a Buy at H.C. Wainwright

May 19, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference

May 15, 2025, 4:15 PM EDT - 1 year ago

Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Earnings release: Q1 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Quarterly report: Q1 2025

May 7, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial

Apr 9, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Study to Fourth Dose Escalation Cohort

Apr 3, 2025, 7:45 AM EDT - 1 year ago

Phio Pharmaceuticals Announces Podium Presentations on INTASYL siRNA Lead Product Candidates PH-762 and PH-894

Mar 31, 2025, 4:00 PM EDT - 1 year ago

Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Earnings release: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Phio Pharmaceuticals Annual report: Q4 2024

Mar 10, 2025, 7:45 AM EDT - 1 year ago

American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting

Mar 5, 2025, 7:45 AM EST - 1 year ago

Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study

Feb 20, 2025, 7:45 AM EST - 1 year ago

Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors

Jan 22, 2025, 7:00 AM EST - 1 year ago

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series

2025-01-21T21:45:15.000Z - 1 year ago

Phio Pharmaceuticals files to sell 5.93M shares of common stock for holders

Jan 21, 2025, 4:15 PM EST - 1 year ago

Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 21, 2025, 7:00 AM EST - 1 year ago

Phio Pharmaceuticals Registration statement: Registration Filing

Jan 16, 2025, 1:00 PM EST - 1 year ago

Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

2025-01-16T16:10:29.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

AZTR BDTX ERNA GTBP IBIO KAPA SLXN

2025-01-15T16:15:41.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

ARDX CGEN CLRB IBIO MRNA

Jan 15, 2025, 7:00 AM EST - 1 year ago

Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

2025-01-14T14:40:47.000Z - 1 year ago

Phio Pharmaceuticals Corp trading resumes

2025-01-14T14:35:14.000Z - 1 year ago

Phio Pharmaceuticals Corp trading halted, volatility trading pause

Jan 14, 2025, 7:00 AM EST - 1 year ago

Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 13, 2025, 7:45 AM EST - 1 year ago

Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762

Nov 14, 2024, 7:00 AM EST - 1 year ago

Phio Pharmaceuticals Earnings release: Q3 2024

Nov 14, 2024, 7:00 AM EST - 1 year ago

Phio Pharmaceuticals Quarterly report: Q3 2024

Aug 14, 2024, 8:00 AM EDT - 2 years ago

Phio Pharmaceuticals Earnings release: Q2 2024

Aug 14, 2024, 8:00 AM EDT - 2 years ago

Phio Pharmaceuticals Quarterly report: Q2 2024

2024-07-26T20:33:23.000Z - 2 years ago

Phio Pharmaceuticals files to sell 1.13M shares of common stock for holders

Jul 26, 2024, 8:00 AM EDT - 2 years ago

Phio Pharmaceuticals Registration statement: Registration Filing

2024-07-08T14:05:37.000Z - 2 years ago

Phio Pharmaceuticals Corp trading resumes

2024-07-08T14:00:37.000Z - 2 years ago

Phio Pharmaceuticals Corp trading halted, volatility trading pause

2024-07-03T20:50:02.000Z - 2 years ago

Phio Pharmaceuticals Corp trading halted, news pending

2024-05-20T21:05:00.000Z - 2 years ago

Phio Pharmaceuticals files $100M mixed securities shelf

May 20, 2024, 8:00 AM EDT - 2 years ago

Phio Pharmaceuticals Registration statement: Registration Filing

2024-05-17T20:46:48.000Z - 2 years ago

Phio Pharmaceuticals files $100M mixed securities shelf

2024-05-17T13:02:30.000Z - 2 years ago

Phio Pharmaceuticals entered into purchase agreement with TRITON Funds

PitaPierogi Aug. 4 at 1:45 PM

$PHIO so you're confident we won't have data centers on pluto? $SPCX $TSLA $AMZN

0 · Reply

HaroldH Aug. 4 at 12:09 PM

1 · Reply

MambaMentality7 Jul. 31 at 11:56 AM

0 · Reply

DERDER Jul. 30 at 10:16 PM

$PHIO The new BOD Todd Plott just filed a form 3, and owns 10% of PHIO stock. With his years of experience, resume, knowledge and expertise, that’s really good news…

1 · Reply

WildernessRefuge Jul. 30 at 5:20 PM

$PHIO ALNY, Alnylam Pharmaceutical, PHIO's soon to be little sister, is on sale today.

0 · Reply

HaroldH Jul. 30 at 8:21 AM

1 · Reply

HaroldH Jul. 29 at 1:53 PM

$PHIO No pumpers about today. Was there not much encouraging in Bob's talk yesterday? Are the former pumpers quietly dumping today? Time is money. I remain bearish.

1 · Reply

DosGatos Jul. 28 at 9:34 PM

$PHIO

0 · Reply

masteroffnone Jul. 28 at 7:55 PM

$PHIO any news on today's presentation?

0 · Reply

DERDER Jul. 27 at 6:49 PM

$PHIO

0 · Reply

Stonkey Jul. 25 at 12:28 AM

$PHIO Yes kiddo's...ain't that sad.

0 · Reply

Rod75b15 Jul. 23 at 1:21 PM

$RZLV $DVLT $QCLS $BIVI $PHIO The Nasdaq 100 is already down 1.6%, I don't expect anything good for the markets today. Still confident about the long term, though.

2 · Reply

MambaMentality7 Jul. 23 at 12:33 PM

$PHIO guys, don’t listen to the noise. All of these couch experts has their thesis. Most of you will get shaken out of your position because you’re bored and have this desire to be where you think the action is:) I totally understand that. Truth is, trading is boring, professional traders know this. Smart money plan on your impatience so they can buy your shares at a big discount and sell it back to you at a huge profit in the excitement when they release the spring for it to run. Smart money do what’s best for them not us and they want us out the picture to go it alone. No resistance, no selling until they’re ready to unload their shares back to weak hands. This stock is bullish and they won’t let it collapse. Set your alerts, go play with the kids:) Hold

1 · Reply

HaroldH Jul. 23 at 4:34 AM

$PHIO A simple question for the little pumpers active here, if the management at $PHIO can screw up two out of three recent press releases, how can you trust them to prepare a good submission to the FDA for approval? I remain bearish.

2 · Reply

LongAllDay Jul. 22 at 7:04 PM

$PHIO might as well convert to an AI Neo Cloud at this point. NOBODY ASKED FOR more dilution more patents more trials consisting of 4 people

0 · Reply

newsfile_corp Jul. 22 at 4:31 PM

https://nfne.ws/306096 $PHIO @PhioPharma11803 #immunooncology #INTASYL #PH762 #PHIO #siRNA #Chemicals #Pharmaceutical #Biotechnology #Healt

0 · Reply

HaroldH Jul. 22 at 11:10 AM

$PHIO More jaw, jaw set for 28th July. Suggests no real price moving news until well into August or later. They wouldn't waste time with jaw, jaw if something real was happening soon. .... . Time is money.

1 · Reply

newsfile_corp Jul. 22 at 11:01 AM

https://nfne.ws/306027 $PHIO @PhioPharma11803 #immunooncology #INTASYL #PH762 #PHIO #siRNA #Chemicals #Pharmaceutical #Biotechnology #Healt

0 · Reply

Rod75b15 Jul. 22 at 8:43 AM

$PHIO https://finance.yahoo.com/healthcare/articles/phio-pharmaceuticals-announces-appointment-dr-110000296.html

1 · Reply

HaroldH Jul. 22 at 3:17 AM

$PHIO one of the most bearish features of $PHIO is that the supporting arguments for bullish comments make no logical sense.

0 · Reply

Stonkey Jul. 21 at 8:39 PM

$PHIO If my aunt had balls she was my uncle....

1 · Reply

MambaMentality7 Jul. 21 at 2:45 PM

$PHIO if it gets past 1.14 we’ll see 1.16 today maybe even a quick 1.17 spike but will drift back into 1.11-1.14 range.

0 · Reply

Market Cap	11.91M
Revenue (ttm)	0.00
Net Income (ttm)	-8.70M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	183,257
Avg Vol	724,106
Day's Range	N/A - N/A
Shares Out	11.62M
Stochastic %K	44%
Beta	0.81
Analysts	Sell
Price Target	$14.00